Nutrien Ltd. Q2 FY26 Results — Earnings Call Analysis
Published 29 May 2026 | Chemicals | Market Cap: ₹33.6K Cr
- Nutrein maintains full-year guidance with expected sales volumes of potash at 14.1 to 14.8 million tonnes and nitrogen at 9.2 to 9.7 million tonnes for 2026. - Nutrien maintains full-year guidance with confidence, supported by strong Q1 performance and ongoing operational excellence.
From Nutrien Ltd.'s Q2 FY26 earnings-call transcript · updated 29 May 2026.
Price
₹69.65
Market Cap
₹33.6K Cr
P/E Ratio
14.2
Revenue Rank
Margin Rank
How does Nutrien Ltd. rank in Chemicals?
Compare Nutrien Ltd. against every Chemicals company this quarter on revenue, margins and earnings-call signals.
📊 Revenue & Sales Performance
Rank 3- →Nutrein maintains full-year guidance with expected sales volumes of potash at 14.1 to 14.8 million tonnes and nitrogen at 9.2 to 9.7 million tonnes for 2026.
- →Strong global demand supports sustaining or increasing sales, with potash shipments forecasted between 74 to 77 million tonnes, indicating potential growth beyond last year's 74.5 million tonnes.
- →High single-digit growth anticipated in proprietary products gross margin, driven by new product launches and expansion in core retail geographies including the U.S., Australia, and international markets.
- →Retail business remains constructive with maintained EBITDA guidance of $1.75 to $1.95 billion for 2026, supported by strong customer engagement and expanding proprietary products.
- →Growth is partly driven by crop nutrient replenishment needs following a large 2025 corn and soybean harvest and increased acres planted in key markets.
- →Ongoing strategic reviews and portfolio optimization, including potential sales in certain business segments, aim to strengthen core growth areas.
📈 Profitability & Margins
Rank 3- →Nutrien maintains full-year guidance with confidence, supported by strong Q1 performance and ongoing operational excellence.
- →High single-digit growth expected in proprietary products gross margin in 2026 due to new product launches, increased demand, and international expansion.
- →No major changes anticipated in margin expectations across product segments except some pressure on phosphate margins in Q2 due to elevated input costs.
- →The company is constructive on potash demand and expects shipment range of 74-77 million tonnes in 2026, testing global logistics and production capacity.
- →Nitrogen segment benefits from higher global benchmarks and low-cost production, driving strong adjusted EBITDA.
- →Retail adjusted EBITDA guidance remains $1.75 billion to $1.95 billion with strong customer engagement during planting season.
- →Nutrien is focused on cost management, asset optimization, and capital allocation to sustain structural free cash flow growth and returns.
- →Overall, market conditions and strategic initiatives support positive earnings outlook and stable profitability for 2026.
🏗️ Capital Expenditure Plans
Yes- →**2026 Capital Expenditures Guidance:** Maintained at $2 billion to $2.1 billion.
- →**Strategic Reviews:**
- → - Phosphate business: Completing detailed assessment of assets and configurations; progressing a sale process with significant initial expressions of interest.
- → - Trinidad nitrogen operations: Evaluating all strategic options, including potential sale, focused on strengthening core North American assets.
- → - Brazilian business: Reviewing components and commenced sales process for Brazilian soybean seed business, expected to complete in H2 2026.
- →**Capital Allocation:** Continuing share repurchases at approximately $55 million per month in Q2 2026.
- →**Investment Focus:** Simplifying the business, strengthening core asset base, improving capital efficiency to drive structural free cash flow growth and sustainable returns.
💰 Fundraising & Capital Structure
No information- →The company completed share repurchases of approximately $550 million last year and reduced adjusted net debt by approximately $600 million.
- →In 2026, they plan to continue share repurchases on a ratable basis with a pace of approximately $55 million per month so far in the second quarter.
- →They see opportunities to further strengthen the balance sheet in 2026.
- →There is no explicit mention of new fundraising through debt or equity during the call.
- →The focus remains on consistent capital allocation, optimizing the portfolio, and maintaining a strong balance sheet.
📋 Order Book & Pipeline
No informationKey Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Continue your research
Others in Chemicals this season
- Westlake Corporation (Q2 FY26)
Westlake Corporation Q2 FY26 quarterly results analysis. HIP segment volume growth driven by strong infrastructure spending and data center cooling needs, suppo
- RPM International Inc. (Q2 FY26)
RPM International Inc. Q2 FY26 quarterly results analysis. RPM expects mid-single-digit revenue growth in Q4 fiscal ’26, aided by M&A (Page 4). Market Cap $13,6
- Solstice Advanced Materials, Inc. (Q2 FY26)
Solstice Advanced Materials, Inc. Q2 FY26 quarterly results analysis. Strong momentum heading into Q2 with 5 planned maintenance outages on track (Page 9). Mark
- International Flavors & Fragrances Inc. (Q2 FY26)
International Flavors & Fragrances Inc. Q2 FY26 quarterly results analysis. The company expects solid top-line growth driven by volume growth across all segment
Frequently Asked Questions
What were Nutrien Ltd. Q2 FY26 results?
- Nutrein maintains full-year guidance with expected sales volumes of potash at 14.1 to 14.8 million tonnes and nitrogen at 9.2 to 9.7 million tonnes for 2026. - Nutrien maintains full-year guidance with confidence, supported by strong Q1 performance and ongoing operational excellence.
What is Nutrien Ltd. share price analysis?
Nutrien Ltd. currently shows a below-average growth signal. The stock trades at a P/E of 14.2 with a market cap of $33,569. Investors should review the full earnings analysis for detailed insights.
Is Nutrien Ltd. planning capital expenditure?
- **2026 Capital Expenditures Guidance:** Maintained at $2 billion to $2.1 billion.
Keep Nutrien Ltd. on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
